OrganoClick AB (STU:0CF) Debt-to-EBITDA : (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:0CF OrganoClick AB STU:0CF
13 GF Score
Price €0.01
GF Value €0.11
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is OrganoClick AB Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

OrganoClick AB's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €5.43 Mil. OrganoClick AB's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €1.67 Mil. OrganoClick AB's annualized EBITDA for the quarter that ended in Jun. 2026 was €0.47 Mil. OrganoClick AB's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 was 14.98.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for OrganoClick AB's Debt-to-EBITDA or its related term are showing as below:

STU:0CF' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -17.55   Med: -3.21   Max: 10.48
Current: -8.73

During the past 13 years, the highest Debt-to-EBITDA Ratio of OrganoClick AB was 10.48. The lowest was -17.55. And the median was -3.21.

STU:0CF's Debt-to-EBITDA is ranked worse than
100% of 1270 companies
in the Chemicals industry
Industry Median: 1.98 vs STU:0CF: -8.73

OrganoClick AB  (STU:0CF) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


OrganoClick AB Debt-to-EBITDA Related Terms


OrganoClick AB Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for OrganoClick AB's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OrganoClick AB Debt-to-EBITDA Chart

OrganoClick AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

OrganoClick AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

STU:0CF vs LIN, SHW, ECL: Debt-to-EBITDA Comparison

For the Specialty Chemicals subindustry, OrganoClick AB's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OrganoClick AB Debt-to-EBITDA vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, OrganoClick AB's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where OrganoClick AB's Debt-to-EBITDA falls into.


STU:0CF
13GF Score
OrganoClick AB STU:0CF
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OrganoClick AB Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

OrganoClick AB's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.8179445478166 + 2.0659424940954) / -1.3605229142594
=-5.79

OrganoClick AB's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(5.4278213432537 + 1.6718438040735) / 0.47391201803044
=14.98

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is OrganoClick AB (STU:0CF) Overvalued in 2026?

Based on GuruFocus' analysis, OrganoClick AB stock appears to be undervalued. The current stock price of €0.01 is trading 89.5% below its estimated GF Value™ of €0.11. GuruFocus considers OrganoClick AB to be Possible Value Trap.

Key valuation signals for STU:0CF:

  • Debt-to-EBITDA:
  • GF Value™: €0.11 vs. price of €0.01 (89.5% below fair value)
  • GF Score™: 13/100 with 3 warning signs

No single metric tells the full story. See the STU:0CF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrganoClick AB Business Description

Other Exchanges ORGC:Sweden0CF:Germany
Address Linjalvagen 9, Taby, SWE, SE-187 66
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
13GF Score

Get the complete analysis for STU:0CF

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.01
Price
€0.11
GF Value